DDrare
Disease
Drug
Target Gene/Pathway
問合せ先
EN
127. 前頭側頭葉変性症
Frontotemporal lobar degeneration
Clinical trials
/
Disease details
臨床試験数
:
90
/
薬物数
:
87
- (
DrugBank
:
30
) /
標的遺伝子数
:
39
-
標的パスウェイ数
:
88
Search
1 trial found
10
50
100
ALL
diseases per page:
Showing 1 to 1 of 1 diseases
Filter by
Reset
No.
TrialID
Date_
enrollment
Date_
registration
Public_title
Scientific_title
Condition
Intervention
Primary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
Phase
Countries
1
NCT05184569
(
ClinicalTrials.gov
)
April 14, 2022
17/12/2021
Veri-T: A Trial of
Verdiperstat
in Patients With svPPA Due to TDP-43 Pathology
Phase 1, Randomized, Double-Blind, Placebo-Controlled, Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy Study of Oral
Verdiperstat
(BHV-3241) in Patients With Semantic Variant Primary Progressive Aphasia (svPPA) Due to TDP-43 Pathology
Phase 1, Randomized, Double-Blind, Placebo-Controlled, Safety, Tolerability, Pharmacokinetics, Pharm ...
Semantic Dementia
Drug:
Verdiperstat
Peter Ljubenkov, MD
National Institutes of Health (NIH);Alzheimer's Association;National Institute on Aging (NIA)
Recruiting
18 Years
85 Years
All
64
Phase 1
United States